Skip to main content
. Author manuscript; available in PMC: 2015 Jun 14.
Published in final edited form as: J Pediatr Hematol Oncol. 2014 Jan;36(1):8–15. doi: 10.1097/MPH.0000000000000000

Table 2.

Demographics

P9201 (n=24) P9605 (n=35) P value
Gender (n/%) 0.43
    male 15 (62.5%) 17 (48.6%)
    female 9 (37.5%) 28 (51.4%)
Race (n/%) 0.16
    White, non-hispanic 16 (66.7%) 31 (88.6%)
    Black, non-hispanic 1 (4.2%) 2 (5.7%)
    Filipino 1 (4.2%) 0 (0%)
    Native American 1 (4.2%) 0 (0%)
    Hispanic 5 (20.8%) 2 (5.7%)
Age at diagnosis* 4.1 (1.1-7.5) 4.9 (2.3-9.8) 0.09
Diagnosis to NP test*^ 8.0 (6.1-9.6) 7.7 (5.2-10.9) 0.48
Diagnosis to MRI*^ 7.7 (5.1-9.6) 7.8 (5.2-10.2) 0.74
End of treatment to NP test*^ 5.6 (3.5-7.1) 5.2 (2.6-8.3) 0.25
End of treatment to MRI*^ 5.3 (2.6-7.1) 5.3 (2.7-7.7) 0.94
*

mean/range in years

^

Only include patients with the particular test, as not all patients had both.